Citadel Advisors’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,359
Closed -$3.1K 15434
2023
Q2
$3.1K Buy
+3,359
New +$2.98K ﹤0.01% 13721
2023
Q1
Sell
-847
Closed -$1.67K 15855
2022
Q4
$2.13K Sell
847
-51,278
-98% -$88K ﹤0.01% 14377
2022
Q3
$72K Buy
52,125
+29,551
+131% +$42.8K ﹤0.01% 11363
2022
Q2
$28K Buy
+22,574
New +$47.3K ﹤0.01% 12272
2021
Q4
Sell
-36,681
Closed -$94K 15100
2021
Q3
$94K Buy
+36,681
New +$93.1K ﹤0.01% 12946
2021
Q2
Sell
-61,308
Closed -$176K 14672
2021
Q1
$191K Buy
61,308
+44,797
+271% +$152K ﹤0.01% 11755
2020
Q4
$43K Buy
+16,511
New +$44.4K ﹤0.01% 10626
2019
Q3
Sell
-17,078
Closed -$67K 9916
2019
Q2
$67K Buy
+17,078
New +$325K ﹤0.01% 8654
2015
Q3
Sell
-1,847
Closed -$68K 9327
2015
Q2
$68K Buy
1,847
+1,408
+321% +$54.1K ﹤0.01% 7436
2015
Q1
$20K Sell
439
-389
-47% -$23.9K ﹤0.01% 7912
2014
Q4
$50K Buy
828
+614
+287% +$44.4K ﹤0.01% 7195
2014
Q3
$18K Buy
+214
New +$25.4K ﹤0.01% 7529
2013
Q4
Sell
-128
Closed -$23K 7211
2013
Q3
$23K Buy
+128
New +$17.1K ﹤0.01% 6154

Other funds holding ACER

Citadel Advisors's ACER Position: Q3 2023 in Review

Citadel Advisors sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 3,359 shares — an estimated $3.1K sold.

Citadel Advisors first reported a position in ACER in Q3 2013 and held it in 13 quarters. The position peaked at $191K in Q1 2021. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.

  • Citadel Advisors reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 3,359 Acer Therapeutics Inc shares in Q3 2023, an estimated $3.1K.
  • Citadel Advisors first reported a position in Acer Therapeutics Inc in Q3 2013 and held it in 13 quarters.
  • Citadel Advisors's Acer Therapeutics Inc position peaked at $191K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.